Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli

Heron Therapeutics announces tax benefits preservation plan adoption

Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return

BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation

GSK to receive USD370m and future royalties in CureVac/BioNTech settlement

Everest Medicines expands I-MAB investment

Perrigo Announces Quarterly Dividend

Ridgetech reports net income of USD10.20m in fiscal year 2025

Gilead receives positive CHMP opinions for lenacapavir as first twice-yearly HIV prevention option in EU

Genomma Lab Internacional announces Q2 2025 results

Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio

Perrigo to divest Dermacosmetics business for up to EUR327m

CVS Health declares quarterly dividend USD0.665 per share

Lilly declares dividend of USD1.50 for Q3

Bavarian Nordic sells US Priority Review Voucher for USD160m